Adaptive Biotechnologies
ADPT
#5169
Rank
S$1.49 B
Marketcap
$10.05
Share price
0.81%
Change (1 day)
173.03%
Change (1 year)

Operating Margin for Adaptive Biotechnologies (ADPT)

Operating Margin as of April 2025 (TTM): -82.70%

According to Adaptive Biotechnologies 's latest financial reports and stock price the company's current Operating Margin is -82.70%. At the end of 2024 the company had an Operating Margin of -89.18%.

Operating Margin history for Adaptive Biotechnologies from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-89.18%-32.6%
2023-132.32%22.37%
2022-108.13%-19.49%
2021-134.31%-9.64%
2020-148.63%84.3%
2019-80.65%-3.35%
2018-83.44%-25.1%
2017-111.40%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
12.07%-114.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-4.58%-94.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.23%-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
5.84%-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.